TalkMed (5G3.SG) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Jul15

TalkMed Shareholders Approve Tamarind Health's Privatization

15:55

Feb25

TalkMed released FY2024 Q3 earnings on February 25 (SGT) with actual revenue of 22.53 M SGD and EPS of 0.0127 SGD

15:00

TalkMed released FY2024 Annual Earnings on February 25, 2025 (SGT) with actual revenue of 78.18 M SGD and EPS of 0.0327 SGD

15:00

TalkMed released FY2024 9 Months Earnings on February 25 (SGT), with actual revenue of 55.65 M SGD and EPS of 0.0191 SGD

15:00

TalkMed released FY2024 Q4 earnings on February 25 (SGT) with actual revenue of 22.53 M SGD and EPS of 0.0127 SGD

15:00

Feb20

TalkMed released FY2023 Q4 earnings on February 20, SGT, with actual revenue of SGD 23 M and EPS of SGD 0.0067

15:00

Schedules & Filings

Schedules

Filings

Feb25

Earning Release(CST)

FY2024 Q4 Earning Release (SGD) Revenue 22.53 M, Net Income 17.59 M, EPS 0.0127

Aug22

Distribution Plan(CST)

Cash dividend 0.014 SGD, Cash dividend 0.009 SGD

Aug15

Distribution Plan(CST)

Cash dividend 0.014 SGD, Cash dividend 0.009 SGD

Stock List

Top Gainers

Top Decliners

Popular

Symbol

Price

%Chg

Change